SCHEMBL6169839

SCHEMBL6169839

COc1ccc(-c2noc(C)c2-c2ccccc2S(N)(=O)=O)cc1F

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 9/20 0.54
PTGS1 P23219 7/20 0.54
CA4 P22748 2/20 0.48
PAX8 Q06710 1/20 0.47
CA2 P00918 2/20 0.46
CA9 Q16790 2/20 0.46
CA12 O43570 1/20 0.46
MT-CO2 P00403 1/20 0.46
CA1 P00915 1/20 0.46
LMNA P02545 1/20 0.46
CA3 P07451 1/20 0.46
ADRB2 P07550 1/20 0.46
ADRB1 P08588 1/20 0.46
CYP3A4 P08684 1/20 0.46
ADORA3 P0DMS8 1/20 0.46
CHRM1 P11229 1/20 0.46
ADRA2B P18089 1/20 0.46
CA6 P23280 1/20 0.46
SLC6A2 P23975 1/20 0.46
PDE4A P27815 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8478643 0.91 PTGS2 (0.53) PTGS2PTGS1CA4CA2CA9
SCHEMBL8478250 0.90 CA4 (0.60) PTGS2PTGS1CA4CA2CA9
SCHEMBL8477502 0.89 PTGS2 (0.51) PTGS2PTGS1CA4CA2CA9
SCHEMBL8473865 0.88 PTGS2 (0.50) PTGS2PTGS1CA4CA2CA9
SCHEMBL8474169 0.88 PTGS2 (0.50) PTGS2PTGS1CA4CA2CA9
SCHEMBL8478260 0.88 PTGS2 (0.50) PTGS2PTGS1CA4CA2CA9
SCHEMBL8473540 0.88 PTGS2 (0.51) PTGS2PTGS1CA4PAX8CA2
SCHEMBL8476629 0.87 PTGS2 (0.54) PTGS2PTGS1CA4CA2CA9
SCHEMBL8478784 0.87 PTGS2 (0.49) PTGS2PTGS1CA4CA2CA9
SCHEMBL8476998 0.87 PAX8 (0.49) PTGS2PTGS1CA4PAX8CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1528059-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle LLC (US) 2005-05-04 EP disclosed
EP-0809636-B1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2002-09-04 EP disclosed
EP-1223167-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle & Co. (US) 2002-07-17 EP disclosed
US-5985902-A TREATING INFLAMMATION AND INFLAMMATION-ASSOCIATED DISORDERS, SUCH AS ARTHRITIS G.D. SEARLE & CO. (US) 1999-11-16 US disclosed
US-5859257-A ANTIINFLAMMATORY, ANTIARTHRITIC AGENTS G. D. SEARLE & CO. (US) 1999-01-12 US disclosed
US-5633272-A Substituted isoxazoles for the treatment of inflammation PHARMACIA & UPJOHN COMPANY LLC 1997-05-27 US disclosed